Connect with GCMI and T3 Labs during the 2017 edition of the Georgia Bio Innovation Summit
Bringing a new medical device from concept to cure to commercialization is an intimidating, complex and expensive process which often stifles innovation instead of encouraging it. What will the future of innovation mean for the healthcare industry as a whole? The Georgia Bio Innovation Summit is a multidisciplinary conference bringing together leaders in biotechnology and biopharmaceuticals, medical devices, academic research, and healthcare IT to discuss this together.
On October 24, 2017 hundreds of healthcare professionals will convene at The Cobb Galleria in Atlanta, Georgia for #GaBioSummit and here is what GCMI and T3 Labs is looking forward to most.
Experiencing a glimpse of the future of innovation
A main focus of the conference is an exhibit hall displaying the latest research, technology and services from companies, universities and other organizations in the Southeast. We look forward to meeting the minds behind these new technologies and introducing them to the multiple resources Atlanta offers to young medtech companies: including the services available at GCMI and T3 Labs. We always leave Georgia Bio with value-added connections.
A few sessions we are particularly interested in
Concurrent Session A 11:00 am – 12:00 pm: Innovations in Laboratory Operations
Lunch Keynote Panel 12:00 pm – 1:30 pm: “Engaging for Success: Patient-Centricity Comes of Age”
Concurrent Session A 3:30 pm – 4:30 pm: Emerging Cutting-Edge Technologies from the Southeast: Genetically-Diversified In Vitro Drug Testing Platform and more
For all medtech innovators seeking to bring new therapy solutions to life; let’s connect at Georgia Bio 2017! GCMI and T3 Labs is sponsoring a break area – stop by and say hello! You can find the conference program here.
The Global Center of Medical Innovation (GCMI) and its wholly owned subsidiary T3 Labs, is the world’s leader in driving efficient medical product innovation. Using our proven high-quality processes, our expert staff works alongside physician innovators, hospital teams, Fortune 500s, start-ups, academic and government funded innovators every day to commercialize innovative medical devices and products, like the microneedle patch, that improve quality based outcomes and delivery of healthcare for patients.
If you are a physician innovator with an idea for an innovative medical device, a company gauging your product’s readiness for preclinical, or seeking a partner in gaining FDA approval, contact GCMI and T3 Labs today to learn how our expert team can help you take your concept through cure, preclinical testing, and commercialization as well as provide surgeons the bioskills training necessary for your innovation.